Evicenter
MarkdownMedical informationP&T meetings
Barzolvolimab (CDX-0159)

Chronic spontaneous urticaria

Launch
Not announced
Last updated
177 sources

Product information and disease descriptionProduct descriptionProduct information

Access and distribution

4 evidence topics · 4 sources

Commercial organization and commercial planning
Distribution channel and patient support model

No evidence found.